Literature DB >> 23603528

The development of medical museums in the antebellum American South: slave bodies in networks of anatomical exchange.

Stephen C Kenny1.   

Abstract

Prior to the American Civil War, museums were enthusiastically promoted in the annual circulars of southern medical colleges as valuable aids to medical education. Using case history narratives, medical college circulars, and announcements, this article examines the social origins of the region's collections of anatomical and pathological specimens and explores the professional agents and organizations responsible for their maintenance and development. The article is also concerned with exploring the racial framework in which these bodies and specimens were sourced and displayed. The social relations embodied in natural history and medical museum collections, and the emerging specialism of "negro medicine," were all elements of a context that subordinated and objectified blackness, as well as permitting and legitimizing the exploitation of black bodies. Medical museums function as a key case study for examining power relations among physicians, slaves, and slave owners, as well as underscoring southern medicine's dependence on slavery for its development.

Mesh:

Year:  2013        PMID: 23603528     DOI: 10.1353/bhm.2013.0016

Source DB:  PubMed          Journal:  Bull Hist Med        ISSN: 0007-5140            Impact factor:   1.314


  3 in total

1.  [Double standards : The Medical Student Kurt Gerstein and the History of Anatomical Body Procurement in Germany].

Authors:  Mathias Schütz
Journal:  NTM       Date:  2018-06

2.  Black Maternal and Infant Health: Historical Legacies of Slavery.

Authors:  Deirdre Cooper Owens; Sharla M Fett
Journal:  Am J Public Health       Date:  2019-08-15       Impact factor: 9.308

3.  Cancer in an Historic Washington DC African American Population and Its Geospatial Distribution.

Authors:  Latifa Jackson; Hasan Jackson; Mariam Mohammed; Nicholas Guthrie; Shihyun Kim; Rita Okolo; Fatimah Jackson
Journal:  Front Oncol       Date:  2018-11-13       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.